home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Aclaris Therapeutics, Inc.

SHARESHARESHARE
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in dermatology. Our lead drug candidate A-101 is being developed as an in-office treatment for seborrheic keratosis (SK), a common non-cancerous skin tumor, as well as for other cutaneous indications, such as common warts.
SHARESHARESHARE

RELATED NEWS


During a White House meeting with senior pharmaceutical executives he told the firms to manufacture more of their drugs in the US. However, he also vowed to help the firms by speeding the approval of new medicines and by cutting taxes....

READ MORE

The pharmaceutical companies have been acquiring new assets and subsidiaries in order to take over their research and intellectual property this has become a growing trend in the pharmaceutical world. Here’s a look at some new acquisitions in pharma. Alkem Laboratories Limited informed the markets on Friday that the company has acquired an new undertaking, as a whole and on a going and running concern basis from Cachet Pharmaceuticals Private Limited, who is a subsidiary of the company. Th...

READ MORE

Pharma is paying for getting too comfy with Donald J. Trump. The president-elect on Wednesday accused the industry of “getting away with murder” on drug prices. Investors had dismissed his earlier pledge to renegotiate costs as campaign rhetoric. By the close of trading on Tuesday, the Nasdaq Biotech Index had risen 8 percent since the election, a rise similar to the Standard & Poor’s 500. Its near 3 percent fall caused by his latest stance should force a broader rethinking....
NY TIMES
READ MORE

Rachel O'Conor booted up her slides and began posing questions to six older adults sitting around a table: How should primary care physicians support patients and caregivers after a diagnosis of dementia? And what stands in the way of getting adequate support? "Please speak louder and go slower," suggested Susanne Smith, a 75-year-old with early-stage Alzheimer's disease. Smith belongs to the Bureau of Sages, a group of vulnerable seniors who advise researchers about what matte...

READ MORE

A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia – an important step on the path toward developing therapies that could slow or halt the course of the disease. The researchers discovered two major groups of genes involved in mutations that result in an overproduction of a protein called tau, a hallmark of the progressive loss of neurons seen in major forms of dementia. The study was largely done in mouse models of dementia,...

READ MORE

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care....

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...